NCT01315132
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +20 more
- Locations
-
- Thomas Jefferson University Philadelphia, Pennsylvania, United States
Clinical trial condition
Lymphoma
Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.
2,141 public trials
305 recruiting studies
Lymphoma trial results
NCT00006721
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Alaska Regional Hospital Cancer Center Anchorage, Alaska, United States
- Fairbanks Cancer Treatment Center at Fairbanks Memorial Hospital Fairbanks, Alaska, United States
- Hembree Mercy Cancer Center at St. Edward Mercy Medical Center Fort Smith, Arkansas, United States
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
NCT07457112
- Conditions
- Blood Protein Disorders, Breast Diseases, Breast Neoplasms, +30 more
- Locations
-
- Faculty of Nursing Zagazig, Egypt
NCT03939026
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- Banner MD Anderson Cancer Center Gilbert, Arizona, United States
- Stanford University Stanford, California, United States
- Colorado Blood Cancer Institute Denver, Colorado, United States
- Moffitt Cancer Center Tampa, Florida, United States
NCT01712490
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
- Locations
-
- Birmingham, Alabama, United States
- Gilbert, Arizona, United States
- Tucson, Arizona, United States
- Burbank, California, United States
NCT02730299
- Conditions
- Acute Leukemia, Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML), +27 more
- Locations
-
- UCLA Los Angeles, California, United States
- City of Hope Los Angeles, California, United States
- Stanford University Cancer Institute Palo Alto, California, United States
- UC San Diego Moores Cancer Center San Diego, California, United States
Completed
Study of VIP152, Venetoclax, and Prednisone (VVIP) in Relapsed/Refractory Lymphoid Malignancies
NCT05371054
- Conditions
- Hematologic Diseases, Hematologic Malignancies, Hematologic Neoplasms, +13 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT01203722
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +14 more
- Locations
-
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
NCT03445858
- Conditions
- Adult Lymphoma, Adult Solid Tumor, Childhood Lymphoma, +15 more
- Locations
-
- Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
NCT04214444
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +14 more
- Locations
-
- GYAN Tours, France